Chester County News and Community Website
HARRISBURG, PA — The Pennsylvania Department of Human Services (DHS) recently released the latest issue of the Positive Approaches Journal, which aims to provide the most recent research and resources for …
Read More
PHILADELPHIA, PA — Department of Human Services (DHS) Acting Secretary Meg Snead joined Maternity Care Coalition (MCC) for a roundtable discussion this week covering the Wolf Administration’s focus on improving …
Read More
WEST CHESTER, PA — Chester County concluded International Overdose Awareness Day, August 31, with a message of HOPE, illuminated on the steps of the Historic Courthouse in West Chester, during its …
Read More
HARRISBURG, PA — Yesterday, Department of Drug and Alcohol Programs (DDAP) Secretary Jen Smith joined with the Pennsylvania chapter of Team Sharing, Inc., a national non-profit organization made up of …
Read More
HARRISBURG, PA — The Pennsylvania Department of Drug and Alcohol Programs (DDAP) has announced findings from a new report highlighting the need to update existing client record policies to address barriers …
Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced its new website to meet consumer demand for information on accessing advanced treatments for depression. The enhanced site also makes it easier …
Read More
DEVON, PA — Eating disorders have skyrocketed during the pandemic, as have mental health disorders in general.
Read More
DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, presented a poster recently at SLEEP 2021, the …
Read More
HARRISBURG, PA — The Department of Human Services (DHS) on Friday highlighted the 2021 Virtual Everyday Lives Conference, which includes as participants direct support professionals, clinical professionals, individuals, and families …
Read More
EXTON, PA — Melior Pharmaceuticals announced that it has signed a “letter of intent” with Adhera Therapeutics, Inc . (OTCPK: ATRX) for the acquisition of Melior’s Parkinson’s disease (PD) candidate, …
Read More